Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Atenolol
Drug ID BADD_D00178
Description Atenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions. Sir James Black, a Scottish pharmacologist, pioneered the use of beta-blockers for the management of angina pectoris in 1958 for which he received the Nobel Prize.[A178429] Beta-blockers quickly became popular in clinical use and where subsequently investigated for use in myocardial infarction, arrhythmias, and hypertension during the 1960s. Later they continued to be investigated for use in heart failure throughout the 1970-1980s. Atenolol itself was developed early on in this history by Alvogen Malta under the trade name Tenormin and received FDA approval in September, 1981.[label] Despite being one of the most widely prescribed beta blockers, evidence suggests atenolol may not significantly reduce mortality, and only modestly reduce the risk of cardiovascular disease in patients with hypertension.[A235850,A235855] A Cochrane review of patients being treated for primary hypertension shows that atenolol shows a risk ratio of 0.88 for cardiovascular disease risk and a risk ratio of 0.99 for mortality.[A235850,A235855] Similar results have been found in other meta-analyses.[A235860,A235865] A meta-analysis of over 145,000 patients showed the risk of stroke in patients taking atenolol may depend on the age of the patient.[A235865] The use of atenolol may need to be based on more patient factors than hypertension alone.[A235850,A235855,A235860,A235865]
Indications and Usage For the management of hypertention and long-term management of patients with angina pectoris
Marketing Status Prescription; Discontinued
ATC Code C07AB03
DrugBank ID DB00335
KEGG ID D00235
MeSH ID D001262
PubChem ID 2249
TTD Drug ID D01UXC
NDC Product Code 60760-787; 50090-2923; 67296-1589; 70934-142; 65862-169; 53002-2138; 68071-4274; 50090-5741; 50090-5363; 50090-3411; 68788-7784; 68788-7528; 52427-429; 0378-0231; 71335-1108; 51079-685; 48589-0007; 0904-7187; 0615-8026; 65841-024; 70518-0379; 65862-168; 65841-022; 70518-3036; 63187-710; 61919-914; 71335-0954; 55700-754; 68788-7535; 60429-027; 68071-4538; 53002-4108; 70934-537; 68382-022; 65862-170; 70518-0399; 71335-0988; 68788-7616; 67296-1270; 55700-755; 63187-092; 52427-430; 51079-684; 52427-431; 61919-854; 50090-5266; 60760-163; 67544-161; 70934-457; 64980-437; 60760-164; 43063-765; 68382-023; 71205-496; 67296-1288; 60687-605; 68071-4751; 68071-4526; 70518-0351; 70934-219; 67296-1726; 70518-2866; 60429-025; 65841-023; 29300-410; 60429-026; 71335-0912; 70518-2939; 0093-0787; 63629-2626; 0093-0753; 0615-8027; 68071-2248; 51604-0012; 67296-1201; 53002-1138; 0378-0757; 50090-0442; 71335-0540; 68071-1772; 60760-643; 70518-0882; 68071-4766; 70934-458; 68071-1771; 68382-024; 55154-5455; 12660-0007; 51079-759; 68071-4527; 42708-012; 0378-0218; 43353-986; 71335-0668; 61294-9994; 71335-1535; 43063-952; 63629-1785; 71205-229; 72189-135; 50090-3410; 72189-152; 68071-4553; 60760-437; 68788-7876; 63187-537; 67544-240; 57451-1115; 38779-0262; 64980-438; 68645-585; 0615-8373; 61919-664; 71335-1264; 50090-5738; 53002-1004; 51927-2467; 42185-7034; 29300-411; 67296-1732; 68071-5162; 50090-5233; 64980-439; 43063-805; 63187-201; 72189-146; 68071-5033; 67544-332; 70934-177; 0615-8372; 0093-0752; 71335-1616; 53002-2004; 29300-412; 61919-581; 63629-8029; 42708-143; 67296-1558; 60760-642; 60760-256; 43353-834; 50090-5408; 50090-3043; 61919-257; 65841-101; 70518-3007; 53002-1108; 70934-463; 49452-0020; 55154-5511; 72789-144; 71205-096; 61919-279; 50090-5367; 51927-0208
Synonyms Atenolol | Tenormine | Tenormin | ICI-66082 | ICI 66082 | ICI66082
Chemical Information
Molecular Formula C14H22N2O3
CAS Registry Number 29122-68-7
SMILES CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2D6P10635T57392Not Available
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
Sudden cardiac deathPotassium voltage-gated channel subfamily H member 2Q12809T202519927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily KQT member 1P51787T495269927398; 10810773; 10082151; 10408028
Sudden cardiac deathSodium channel protein type 5 subunit alphaQ14524T397169927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily E member 1P15382Not Available9927398; 10810773; 10082151; 10408028
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pulmonary congestion24.03.08.001; 22.01.03.002; 02.05.02.0020.000029%Not Available
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pulmonary fibrosis22.01.02.0060.000029%
Pulmonary oedema22.01.03.003; 02.05.02.0030.000185%
Pulse absent13.14.04.0050.000222%Not Available
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
Pustular psoriasis23.03.14.0060.000074%Not Available
Pyrexia08.05.02.003--
Rales22.02.04.0040.000074%Not Available
Rash23.03.13.001--Not Available
Rash erythematous23.03.06.003--Not Available
Rash papular23.03.13.0170.000074%Not Available
Rash pustular23.03.10.003; 11.01.12.0020.000111%
Raynaud's phenomenon24.04.03.003--Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.0010.000222%
Renal cyst16.27.01.001; 20.01.04.0010.000111%Not Available
Renal disorder20.01.02.0020.000111%Not Available
Renal failure20.01.03.005--Not Available
Renal pain20.02.03.0030.000074%Not Available
Renal tubular necrosis20.01.07.0030.000111%Not Available
Respiratory acidosis22.02.02.004; 14.01.04.0020.000111%Not Available
Respiratory arrest22.02.01.0090.000039%Not Available
Respiratory depression22.02.01.010; 17.02.05.0470.000185%Not Available
Respiratory distress22.02.01.012--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Restlessness19.11.02.002; 17.02.05.0210.000185%
Retinal artery occlusion24.01.07.003; 06.10.01.0050.000111%Not Available
Retinal vein occlusion06.10.01.010; 24.01.07.0060.000074%Not Available
Rhabdomyolysis15.05.05.002--
Rheumatoid arthritis15.01.03.001; 10.04.06.0010.000074%Not Available
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 17 Pages